Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OPTIMIZERx Corp OPRX

Healthcare Medical Devices
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables... see more

Recent & Breaking News (NDAQ:OPRX)

LifeMD Appoints William J. Febbo to its Board of Directors

GlobeNewswire June 20, 2023

OptimizeRx's CEO Provides 2023 Midyear Strategic Update

GlobeNewswire May 24, 2023

OptimizeRx's Karina Castagna Named One of the 2023 PM360 ELITE 100

GlobeNewswire May 18, 2023

OptimizeRx to Participate in Upcoming Investor Conferences

GlobeNewswire May 15, 2023

OptimizeRx Reports First Quarter 2023 Financial Results

GlobeNewswire May 10, 2023

Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance

GlobeNewswire May 2, 2023

OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET

GlobeNewswire April 26, 2023

OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report

GlobeNewswire April 4, 2023

Financial Times Ranks OptimizeRx Amongst The Americas' Fastest Growing Companies for the Fourth Consecutive Year

GlobeNewswire March 29, 2023

OptimizeRx Authorizes $15 Million Share Repurchase Program

GlobeNewswire March 14, 2023

OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients

GlobeNewswire March 9, 2023

OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 8, 2023

OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET

GlobeNewswire February 23, 2023

OptimizeRx's Karina Castagna Named to MM+M's 40 Under 40 List of the Medical Marketing Industry's Brightest Young Stars

GlobeNewswire February 9, 2023

OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference

GlobeNewswire January 4, 2023

OptimizeRx to Participate in Upcoming Investor Conferences

GlobeNewswire November 28, 2022

OptimizeRx Reports Third Quarter 2022 Financial Results

GlobeNewswire November 8, 2022

OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event

GlobeNewswire October 20, 2022

OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET

GlobeNewswire October 19, 2022

OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution

GlobeNewswire October 11, 2022